跳至主要内容
临床试验/NL-OMON22961
NL-OMON22961招募中不适用

Double umbilical cord blood transplantation in high-risk hematological patients.<br>A phase II study focussing on the mechanism of graft predominance.

HOVON Data Center0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
70

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 18-65 years inclusive;
  • 2. Diagnosis of poor-risk hematological malignancy or (V)SAA relapsing after or failing immunosuppressive therapy and meeting the criteria for a MUD allo SCT;

排除标准

  • 1. Bilirubin and/or transaminases > 2.5 x normal value;
  • 2. Creatinine clearance < 40 ml/min;

研究者

发起方
HOVON Data Center

相似试验

进行中(未招募)
不适用
Double umbilical cord blood transplantation in high-risk hematological patients.A phase II study focussing on the mechanism of graft predominancePatients with high-risk hematological diseases, who need a allogeneic stem cell transplantation but who lack a matched unrelated donorMedDRA version: 14.1Level: PTClassification code 10061187Term: Haematopoietic neoplasmSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-001188-55-BEHOVON Foundation70
招募中
2 期
Double umbilical cord blood transplantation in high-risk haematological patients. A phase II study focussing on the mechanism of graft predominance
NL-OMON39426HOVO70
进行中(未招募)
不适用
Double umbilical cord blood transplantation in high-risk hematological patients.A phase II study focussing on the mechanism of graft predominancePatients with high-risk hematological diseases, who need a allogeneic stem cell transplantation but who lack a matched unrelated donorMedDRA version: 14.1Level: PTClassification code 10061187Term: Haematopoietic neoplasmSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-001188-55-NLHOVON Foundation
已完成
2 期
Clinical phase II study of double-unit cord blood transplantation for hematological malignancies.(C-SHOT 0507)
JPRN-C000000359A Research Grant on Human Genome, Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare: Research on advancement and safety security of HSCT using umbilical cord blood.70
终止
1 期
Double Cord Blood Transplant for Patients With Malignant and Non-malignant DisordersImmunodeficienciesLymphomaLeukemiaAnemiaNeuroblastoma
NCT00801931Columbia University1
Double umbilical cord blood transplantation in... | 临床试验